Canna~Fangled Abstracts Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis Neurodegener Dis Manag. 2022 Jun 16. doi: 10.2217/nmt-2022-0014. Online ahead of print. Armando Creta 1, Luana Gilio 1, Diego…Freedom WaresJune 16, 2022
Canna~Fangled Abstracts Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry Journal List > J Pain Res > v.15; 2022 > PMC8819705 J Pain Res. 2022;…Freedom WaresFebruary 2, 2022
Canna~Fangled Abstracts A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery Journal List > Med Cannabis Cannabinoids > v.5(1); 2022 > PMC8832248 Med Cannabis Cannabinoids. 2022; 5(1):…Freedom WaresJanuary 18, 2022
Canna~Fangled Abstracts Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome? Journal List BMJ Case Rep PMC8264571 As a library, NLM provides access to scientific…Freedom WaresJuly 6, 2021
Canna~Fangled Abstracts Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship. Clin Neuropharmacol. 2018 Jul 18. doi: 10.1097/WNF.0000000000000294. Contin M, Mancinelli L, Perrone A1, Sabattini L1,…Freedom WaresJuly 20, 2018
Canna~Fangled Abstracts Palatability and oral cavity tolerability of THC:CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: a pilot study. Neurodegener Dis Manag. 2018 Apr 23. doi: 10.2217/nmt-2017-0056. Lus G1, Cantello R2, Danni MC3, Rini…Freedom WaresApril 23, 2018
Canna~Fangled Abstracts Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity. Drugs. 2017 Mar 14. doi: 10.1007/s40265-017-0720-6. Keating GM1. Author information Abstract Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (THC/CBD,…Freedom WaresMarch 14, 2017
Canna~Fangled Abstracts Tetrahydrocannabinol: Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice. 2016 Oct 13;76(5-6):216-226. Vermersch P1, Trojano M. Author information Abstract BACKGROUND: Tetrahydrocannabinol:cannabidiol (THC:CBD) oromucosal spray (Sativex®) is…Freedom WaresOctober 13, 2016
Canna~Fangled Abstracts Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study. 2015 Nov 17;74(3-4):178-185. Trojano M1, Vila C. Author information Abstract BACKGROUND: The prospective, non-interventional Mobility Improvement…Freedom WaresNovember 17, 2015
Canna~Fangled Abstracts Sativex® and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis. 2015 Aug 20. Leocani L1, Nuara A, Houdayer E, Schiavetti I, Del Carro U, Amadio S, Straffi L, Rossi P, Martinelli V, Vila C, Sormani…Freedom WaresAugust 20, 2015